Literature DB >> 14038204

Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses.

R H PARROTT, A J VARGOSKO, J A BELL, R M CHANOCK.   

Abstract

Entities:  

Keywords:  VIRUS DISEASES/epidemiology

Mesh：

Year:  1962        PMID： 14038204      PMCID： PMC1523067          DOI： 10.2105/ajph.52.6.907

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  17 in total

1.  Antigenic relationships among the newer myxoviruses (parainfluenza).

Authors:  M K COOK; B E ANDREWS; H H FOX; H C TURNER; W D JAMES; R M CHANOCK
Journal:  Am J Hyg       Date:  1959-05

2.  Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1).

Authors:  D A TYRRELL; M L BYNOE; K B PETERSEN; R N SUTTON; M S PEREIRA
Journal:  Br Med J       Date:  1959-11-07

3.  An outbreak of pneumonia caused by type I haemadsorption virus.

Authors:  A G BUKRINSKAYA; E A PAKTORIS
Journal:  Acta Virol       Date:  1960-05       Impact factor: 1.162

4.  Infection of human volunteers with type 2 hemadsorption virus.

Authors:  T E REICHELDERFER; R M CHANOCK; J E CRAIGHEAD; R J HUEBNER; H C TURNER; W JAMES; T G WARD
Journal:  Science       Date:  1958-10-03       Impact factor: 47.728

5.  Characteristics of para-influenza 1 (HA-2) virus. I. Incidence of infection and clinical features in adults.

Authors:  E C DICK; W J MOGABGAB; B HOLMES
Journal:  Am J Hyg       Date:  1961-05

6.  Para-influenza viruses 1, 2, and 3: suggested names for recently described myxoviruses.

Authors:  C H ANDREWES; F B BANG; R M CHANOCK; V M ZHDANOV
Journal:  Virology       Date:  1959-05       Impact factor: 3.616

7.  Para-influenza viruses in association with acute laryngotracheobronchitis, Toronto, 1960-61.

Authors:  D M MCLEAN; T E ROY; M J O'BRIEN; J C WYLLIE; E J MCQUEEN
Journal:  Can Med Assoc J       Date:  1961-08-05       Impact factor: 8.262

8.  Isolation of cytopathogenic agents from the respiratory tract in acute laryngotracheobronchitis.

Authors:  A J BEALE; D L McLEOD; W STACKIW; A J RHODES
Journal:  Br Med J       Date:  1958-02-08

9.  Newly recognized myxoviruses from children with respiratory disease.

Authors:  R M CHANOCK; R H PARROTT; K COOK; B E ANDREWS; J A BELL; T REICHELDERFER; A Z KAPIKIAN; F M MASTROTA; R J HUEBNER
Journal:  N Engl J Med       Date:  1958-01-30       Impact factor: 91.245

10.  Association of a new type of cytopathogenic myxovirus with infantile croup.

Authors:  R M CHANOCK
Journal:  J Exp Med       Date:  1956-10-01       Impact factor: 14.307
View more
  32 in total

1.  Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector.

Authors:  A A Haller; T Miller; M Mitiku; K Coelingh
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  PARAINFLUENZA INFECTIONS IN THE COMMUNITY.

Authors:  J E BANATVALA; T B ANDERSON; B B REISS
Journal:  Br Med J       Date:  1964-02-29

3.  PARA-INFLUENZA 2 VIRUS INFECTIONS IN ADULT VOLUNTEERS.

Authors:  D TAYLOR-ROBINSON; M L BYNOE
Journal:  J Hyg (Lond)       Date:  1963-12

4.  AN AETIOLOGICAL STUDY OF RESPIRATORY INFECTION IN CHILDREN, EDINBURGH CITY HOSPITAL, 1961-1963.

Authors:  G E URQUHART; M A MOFFAT; M A CALDER; G M CRUICKSHANK
Journal:  J Hyg (Lond)       Date:  1965-06

5.  In Memoriam: Robert M. Chanock, MD, 1924–2010.

Authors:  Albert Z Kapikian; David M Morens; Anthony S Fauci
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

6.  Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates.

Authors:  Anne Schaap-Nutt; Caraline Higgins; Emerito Amaro-Carambot; Sheila M Nolan; Christopher D'Angelo; Brian R Murphy; Peter L Collins; Alexander C Schmidt
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

7.  Infectious Diseases: Annual Review of Significant Publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1963-08       Impact factor: 2.401

8.  Proteins associated with human parainfluenza virus type 3.

Authors:  R C Jambou; N Elango; S Venkatesan
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

9.  Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.

Authors:  Anne Schaap-Nutt; Margaret A Scull; Alexander C Schmidt; Brian R Murphy; Raymond J Pickles
Journal:  Vaccine       Date:  2010-02-20       Impact factor: 3.641

10.  Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Margaret A Scull; Emerito Amaro-Carambot; Machiko Nishio; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2009-12-07       Impact factor: 3.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.